Table 2.

Performance of anthropometric, clinical, and laboratory characteristics in predicting all-cause mortality and symptomatic cerebrovascular symptoms.

Characteristic	Survivors (n = 58)	Non-Survivors (n = 24)	Cut-Off	Sensibility	Specificity	AUC	p
sST2, ng/mL	38.0 ± 30.0	117.0 ± 103.9	>98.44	54.2	98.3	0.791	<0.0001
Tryglicerides, mg/dL	104.0 ± 45.6	140.5 ± 66.4	>105	70.8	67.2	0.685	=0.0043
Characteristic	Asymptomatic (n = 37)	Symptomatic (n = 45)	Cut-Off	Sensibility	Specificity	AUC	p
Total Cholesterol, mg/dL	146.6 ± 31.6	173.7 ± 45.3	>175.6	56.8	88.9	0.722	=0.0002
HDL-C, mg/dL	54.2 ± 21.3	44.9 ± 10.5	≤55	89.2	37.8	0.628	=0.0363
LDL-C, mg/dL	70.9 ± 26.1	104.1 ± 37.9	>95	70.3	86.7	0.775	<0.0001
Tryglicerides, mg/dL	107.5 ± 54.2	123.5 ± 54.8	>94	75.7	51.1	0.623	=0.0466
sST2, ng/mL	45.4 ± 41.4	80.3 ± 92.1	>95.43	32.4	91.1	0.609	0.0855

Abbreviations: AUC: area under the curve; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; sST2: soluble suppressor of tumorigenicity.